XAIN Stock Overview
Xtrackers - MSCI Indonesia Swap UCITS ETF is an exchange traded fund launched by Deutsche Asset Management S.A.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Xtrackers - MSCI Indonesia Swap UCITS ETF Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$14.11 |
| 52 Week High | US$15.87 |
| 52 Week Low | US$13.59 |
| Beta | 0 |
| 1 Month Change | -8.85% |
| 3 Month Change | -3.95% |
| 1 Year Change | -6.57% |
| 3 Year Change | 27.91% |
| 5 Year Change | 0.47% |
| Change since IPO | 31.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| XAIN | DE Capital Markets | DE Market | |
|---|---|---|---|
| 7D | -1.1% | -0.8% | -2.0% |
| 1Y | -6.6% | 17.8% | -0.3% |
Return vs Industry: XAIN underperformed the German Capital Markets industry which returned 17.8% over the past year.
Return vs Market: XAIN underperformed the German Market which returned -0.3% over the past year.
Price Volatility
| XAIN volatility | |
|---|---|
| XAIN Average Weekly Movement | 2.3% |
| Capital Markets Industry Average Movement | 4.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: XAIN has not had significant price volatility in the past 3 months.
Volatility Over Time: XAIN's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | n/a | n/a |
Xtrackers - MSCI Indonesia Swap UCITS ETF is an exchange traded fund launched by Deutsche Asset Management S.A. The fund is managed by Deutsche Asset Management (UK) Limited. It invests in public equity markets of Indonesia.
Xtrackers - MSCI Indonesia Swap UCITS ETF Fundamentals Summary
| XAIN fundamental statistics | |
|---|---|
| Market cap | €46.88m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs XAIN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| XAIN income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did XAIN perform over the long term?
See historical performance and comparison